Plasma galectin-3 levels do not differ in systemic lupus erythematosus patients.

Chan-Na ZhaoYan-Mei MaoLi-Na LiuQian WuYi-Lin DanHai-Feng Pan

Published in: International journal of rheumatic diseases (2019)

In summary, plasma galectin-3 level was not significantly different between SLE patients and controls (P = .982). Further studies are needed to elucidate the role of galectin-3 in SLE.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
systemic lupus erythematosus
chronic kidney disease
prognostic factors